Here's the live share price of Sanofi India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Sanofi India has declined 9.73% CAGR. Over the past year, the corresponding return has been -26.95%.
Sanofi India’s current P/E of 26.73x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Low Price Blue Chips stocks Screener.
| Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) | 
|---|---|---|---|---|---|---|---|
| Sanofi India | 1.69 | 1.94 | -17.82 | -19.59 | -29.33 | -5.10 | -9.73 | 
| Sun Pharmaceutical Industries | 0.24 | 4.12 | -0.11 | -6.84 | -7.87 | 18.80 | 29.61 | 
| Divi's Laboratories | 0.89 | 16.39 | 0.70 | 8.95 | 12.77 | 22.60 | 16.18 | 
| Cipla | -2.73 | 1.76 | -0.88 | 0.97 | -0.82 | 9.72 | 15.36 | 
| Torrent Pharmaceuticals | 0.55 | 0.98 | -3.84 | 10.50 | 12.37 | 29.69 | 22.92 | 
| Mankind Pharma | 0.58 | 0.29 | -4.75 | 2.68 | -8.28 | 19.76 | 11.42 | 
| Dr. Reddy's Laboratories | -6.37 | -3.54 | -5.41 | 1.63 | -5.66 | 10.70 | 4.22 | 
| Zydus Lifesciences | -1.94 | -0.57 | 1.66 | 11.37 | -1.57 | 31.49 | 18.74 | 
| Lupin | 0.57 | -1.98 | 0.71 | -5.60 | -11.15 | 40.64 | 16.42 | 
| Alkem Laboratories | -0.43 | 1.14 | 9.75 | 8.86 | -4.52 | 20.51 | 15.96 | 
| Aurobindo Pharma | 1.46 | 1.28 | -3.50 | -9.17 | -21.13 | 26.93 | 7.34 | 
| Abbott India | -1.07 | -0.83 | -13.94 | -3.67 | 2.24 | 15.44 | 14.12 | 
| Glenmark Pharmaceuticals | 3.55 | -3.86 | -11.72 | 36.89 | 11.21 | 66.99 | 31.70 | 
| Laurus Labs | 4.84 | 11.23 | 10.95 | 56.36 | 97.19 | 28.74 | 24.89 | 
| Biocon | 4.97 | 8.80 | -3.61 | 18.31 | 19.25 | 11.87 | -1.35 | 
| GlaxoSmithKline Pharmaceuticals | -4.99 | -3.03 | -17.26 | -8.39 | -3.93 | 23.79 | 12.26 | 
| Anthem Biosciences | -0.35 | -7.04 | -5.45 | -1.78 | -1.78 | -0.60 | -0.36 | 
| Ipca Laboratories | 1.61 | -2.97 | -12.56 | -6.54 | -18.86 | 12.52 | 2.18 | 
| Gland Pharma | -1.40 | -3.44 | -7.41 | 36.14 | 15.84 | 2.33 | 0.99 | 
| Ajanta Pharma | 1.97 | 2.59 | -10.54 | -4.78 | -19.89 | 23.76 | 18.58 | 
Over the last one year, Sanofi India has declined 29.33% compared to peers like Sun Pharmaceutical Industries (-7.87%), Divi's Laboratories (12.77%), Cipla (-0.82%). From a 5 year perspective, Sanofi India has underperformed peers relative to Sun Pharmaceutical Industries (29.61%) and Divi's Laboratories (16.18%).
| Day | SMA | EMA | 
|---|---|---|
| 5 | 4,729.56 | 4,753.34 | 
| 10 | 4,713.69 | 4,739.6 | 
| 20 | 4,714.69 | 4,761.53 | 
| 50 | 4,933.38 | 4,948.46 | 
| 100 | 5,413.27 | 5,231.7 | 
| 200 | 5,581.62 | 5,604.14 | 
In the latest quarter, Sanofi India remained same as its previous close in promoter holding, while DII stake decreased to 22.28%, FII holding fell to 5.57%, and public shareholding moved up to 11.75% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
| Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) | 
|---|---|---|---|
| 3,37,894 | 0.71 | 157.12 | |
| 2,51,576 | 0.25 | 116.98 | |
| 2,50,365 | 0.39 | 116.42 | |
| 2,30,272 | 1.32 | 107.08 | |
| 2,26,766 | 0.27 | 105.45 | |
| 2,13,992 | 0.15 | 99.51 | |
| 1,52,371 | 0.15 | 70.85 | |
| 1,47,988 | 0.23 | 68.81 | |
| 75,252 | 0.55 | 34.99 | |
| 63,911 | 0.1 | 29.72 | 
* Excluding Index & Arbitrage Funds
| Date Time | Announcement | 
|---|---|
| Oct 31, 2025, 12:37 AM IST | Sanofi India - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | 
| Oct 29, 2025, 9:26 PM IST | Sanofi India - Announcement under Regulation 30 (LODR)-Investor Presentation | 
| Oct 29, 2025, 7:31 PM IST | Sanofi India - Announcement under Regulation 30 (LODR)-Dividend Updates | 
| Oct 29, 2025, 7:25 PM IST | Sanofi India - Financial Results For The Quarter And Nine Months Ended 30Th September 2025 | 
| Oct 29, 2025, 6:59 PM IST | Sanofi India - Board Meeting Outcome for Financials Results For The Quarter Ended 30Th September 2025 And Recommendation Of I | 
Sanofi India Ltd. is a Public Limited Listed company incorporated on 02/05/1956 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1956PLC009794 and registration number is 009794. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 2013.20 Cr. and Equity Capital is Rs. 23.00 Cr. for the Year ended 31/12/2024.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sanofi India is ₹4,796.50 as on Oct 30, 2025.
The Sanofi India is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Sanofi India is ₹11,046.64 Cr as on Oct 30, 2025.
Today’s highest and lowest price of Sanofi India are ₹4,830.75 and ₹4,750.30.
The 52-week high/low is the highest and lowest price at which Sanofi India stock has traded in the past 52-week or nearly a year. The 52-week high of Sanofi India is ₹6,836.00 and 52-week low of Sanofi India is ₹4,145.90 as on Oct 30, 2025.
The Sanofi India has shown returns of 1.43% over the past day, 3.13% for the past month, -18.45% over 3 months, -26.95% over 1 year, -5.1% across 3 years, and -9.73% over 5 years.
P/E ratio of and PB ratio of Sanofi India are 26.73 and 14.41 on Oct 30, 2025. While the company gives a dividend yield of 2.44 per annum.